New Delhi: Drug firm IOL Chemicals & Pharmaceuticals on Thursday said that it has received nod from the Korean Ministry of Food and Drug Safety for its active pharmaceutical ingredient (API) products -- Ibuprofen and Fenofibrate.
The approval by the Korean Ministry of Food and Drug Safety re-establishes the company's efforts to keep the highest quality standards and to increase presence in the regulated markets, IOL Chemicals & Pharmaceuticals said in a regulatory filing.
Also Read: Lupin Launches Generic Equivalent Of Northera Capsules In US
This will strengthen the company's presence in the South Korean market, it added.
Ibuprofen is used to treat a range of aches and pains, including back pain, period pain and toothache. Fenofibrate is used to treat the symptoms of high cholesterol and triglycerides in the blood.
Also Read: Lupin Unveils Generic Duexis Tablets In US
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!